C. Rupprecht, Rhabdoviruses: Rabies Virus. Medical Microbiology, p.61, 1996.

A. Giesen, D. Gniel, and C. Malerczyk, 30 years of rabies vaccination with Rabipur: a summary of clinical data and global experience, Expert Review of Vaccines, vol.14, issue.3, pp.351-67, 2015.
DOI : 10.1586/14760584.2015.1011134

T. Hemachudha, Antemortem Diagnosis of Human Rabies, Clinical Infectious Diseases, vol.39, issue.7, pp.1085-1086, 2004.
DOI : 10.1086/423813

R. Oliveira, N. Takaoka, P. Brandao, P. Carnieli, . Jr et al., Postmortem Confirmation of Human Rabies Source, Emerging Infectious Diseases, vol.12, issue.5, pp.867-869, 2006.
DOI : 10.3201/eid1205.051425

M. Burton and D. Mabey, The Global Burden of Trachoma: A Review, PLoS Neglected Tropical Diseases, vol.365, issue.36, p.460, 2009.
DOI : 10.1371/journal.pntd.0000460.t003

H. Taylor, M. Burton, D. Haddad, S. West, and W. H. Trachoma, The Lancet, pp.2142-2152, 2014.

R. Bailey, C. Osmond, D. Mabey, H. Whittle, and M. Ward, Analysis of the Household Distribution of Trachoma in a Gambian Village Using a Monte Carlo Simulation Procedure, International Journal of Epidemiology, vol.18, issue.4, pp.944-51, 1989.
DOI : 10.1093/ije/18.4.944

N. Congdon, S. West, S. Vitale, S. Katala, and B. Mmbaga, Exposure to Children and Risk of Active Trachoma in Tanzanian Women, American Journal of Epidemiology, vol.137, issue.3, pp.366-72, 1993.
DOI : 10.1093/oxfordjournals.aje.a116683

B. Thylefors, C. Dawson, B. Jones, S. West, and H. Taylor, A simple system for the assessment of trachoma and its complications, Bull World Health Organ, vol.65, pp.477-83, 1987.

H. Kuper, A. Solomon, J. Buchan, M. Zondervan, A. Foster et al., A critical review of the SAFE strategy for the prevention of blinding trachoma. The Lancet Infectious Diseases, pp.372-381, 2003.

A. Baneke and . Review, Review: Targeting trachoma: Strategies to reduce the leading infectious cause of blindness, Travel Medicine and Infectious Disease, vol.10, issue.2, pp.92-96, 2012.
DOI : 10.1016/j.tmaid.2012.01.005

S. Sakyi, S. Aboagye, I. Otchere, and D. Yeboah-manu, Clinical and Laboratory Diagnosis of Buruli Ulcer Disease: A Systematic Review, Canadian Journal of Infectious Diseases and Medical Microbiology, vol.22, issue.2, p.5310718, 2016.
DOI : 10.1371/journal.pntd.0004247

W. Meyers, W. Shelly, D. Connor, and E. Meyers, Human Mycobacterium ulcerans infections eveloping at sites of trauma to skin, Am J Trop Med Hyg, vol.23, issue.5, pp.919-942, 1974.

B. Ross, Detection of Mycobacterium ulcerans in environmental samples during an outbreak of ulcerative disease, Appl Environ Microbiol, vol.63, pp.4135-4138, 1997.

J. Hayman, Infection, International Journal of Epidemiology, vol.20, issue.4, pp.1093-1098, 1991.
DOI : 10.1093/ije/20.4.1093

F. Portaels, P. Elsen, A. Guimaraes-peres, P. Fonteyne, and W. Meyers, Insects in the transmission of Mycobacterium ulcerans infection, The Lancet, vol.353, issue.9157, p.986, 1999.
DOI : 10.1016/S0140-6736(98)05177-0

L. Marsollier, Aquatic Insects as a Vector for Mycobacterium ulcerans, Applied and Environmental Microbiology, vol.68, issue.9, pp.4623-4631, 2002.
DOI : 10.1128/AEM.68.9.4623-4628.2002

J. Kanga, aspects épidémiologiques, cliniques et thérapeutiques en Côte d'Ivoire, Med Trop, vol.64, pp.238-242, 2004.

P. Johnson, Consensus recommendations for the diagnosis, treatment and control of Mycobacterium ulcerans infection (Bairnsdale or Buruli ulcer) in Victoria, Australia, Medical Journal of Australia, vol.186, pp.64-68, 2007.

O. Brien, D. Mcdonald, A. Callan, P. Robson, M. Friedman et al., Successful Outcomes with Oral Fluoroquinolones Combined with Rifampicin in the Treatment of Mycobacterium ulcerans: An Observational Cohort Study, PLoS Neglected Tropical Diseases, vol.5, issue.8, p.1473
DOI : 10.1371/journal.pntd.0001473.s001

E. Caumes and M. A. Lèpre, Médecine tropicale, 6e édition, 2012.

R. Truman, Probable Zoonotic Leprosy in the Southern United States, New England Journal of Medicine, vol.364, issue.17, pp.1626-1633, 2011.
DOI : 10.1056/NEJMoa1010536

F. Reibel, E. Cambaud, and A. A. , Update on the epidemiology, diagnosis, and treatment of leprosy, M??decine et Maladies Infectieuses, vol.45, issue.9
DOI : 10.1016/j.medmal.2015.09.002

B. Veyseller, Olfactory Dysfunction and Olfactory Bulb Volume Reduction in Patients with Leprosy Indian J Otolaryngol Head Neck Surg, pp.261-265, 2012.

M. Marksa, A. Solomon, and D. Mabey, Endemic treponemal diseases, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.108, issue.10, pp.601-607, 2014.
DOI : 10.1093/trstmh/tru128

M. Marks, Challenges and key research questions for yaws eradication, The Lancet Infectious Diseases, vol.15, issue.10, pp.1220-1225, 2015.
DOI : 10.1016/S1473-3099(15)00136-X

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668588

A. Solomon, Trachoma and Yaws: Common Ground ? PLoS Negl Trop Dis, Dec, vol.39, issue.12, p.4071, 2015.
DOI : 10.1371/journal.pntd.0004071

URL : http://doi.org/10.1371/journal.pntd.0004071

A. Flisser, Portrait of Human Tapeworms, Journal of Parasitology, vol.90, issue.4, pp.914-920, 2004.
DOI : 10.1645/GE-3354CC

H. Garcia, A. Gonzalez, C. Evans, and R. Gilman, TAENIA SOLIUM CYSTICERCOSIS, Infectious Disease Clinics of North America, vol.14, issue.1, pp.547-556, 2003.
DOI : 10.1016/S0891-5520(05)70220-8

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103219

M. Hawk, K. Shahlaie, K. Kim, and J. Theis, Neurocysticercosis: a review, Surgical Neurology, vol.63, issue.2, pp.123-155, 2005.
DOI : 10.1016/j.surneu.2004.02.033

S. Rath, S. Honavar, M. Naik, R. Anand, B. Agarwal et al., Orbital Cysticercosis: Clinical Manifestations, Diagnosis, Management, and Outcome, Ophthalmology, vol.117, issue.3, pp.600-605, 2010.
DOI : 10.1016/j.ophtha.2009.07.030

URL : http://doi.org/10.1016/j.ophtha.2009.07.030

R. Kraft, Cysticercosis: an emerging parasitic disease, Am Fam Physician, vol.75, pp.91-96, 2007.

H. Garcia, Current Consensus Guidelines for Treatment of Neurocysticercosis, Clinical Microbiology Reviews, vol.15, issue.4, pp.747-56, 2002.
DOI : 10.1128/CMR.15.4.747-756.2002

P. Palmer and M. Reede, The Imaging of Tropical Diseases, 2000.

J. Eckert and P. Deplazes, Biological, Epidemiological, and Clinical Aspects of Echinococcosis, a Zoonosis of Increasing Concern, Clinical Microbiology Reviews, vol.17, issue.1, pp.107-135, 2004.
DOI : 10.1128/CMR.17.1.107-135.2004

P. Torgerson, Alveolar echinococcosis: From a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years, Journal of Hepatology, vol.49, issue.1, pp.72-77, 2008.
DOI : 10.1016/j.jhep.2008.03.023

T. Pakala, M. Molina, and G. Wu, Hepatic Echinococcal Cysts: A Review, J Clin Transl Hepatol, 2016.

M. Sarkar, R. Pathania, A. Jhobta, B. Thakur, and R. Chopra, Cystic pulmonary hydatidosis. Lung India, pp.179-91, 2016.
DOI : 10.4103/0970-2113.177449

URL : http://doi.org/10.4103/0970-2113.177449

G. Nunnari, M. Pinzone, S. Gruttadauria, B. Celesia, G. Madeddu et al., Hepatic echinococcosis: Clinical and therapeutic aspects, World Journal of Gastroenterology, vol.18, issue.13, pp.1448-58, 2012.
DOI : 10.3748/wjg.v18.i13.1448

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319940

A. Ito, L. Ma, M. Paul, J. Stefaniak, and Z. Pawlowski, Evaluation of Em18-, Em16-, Antigen B-Western blots, Em2plus-ELISA and four other tests for differential serodiagnosis of alveolar and cystic echinococcosis patients in Poland, Parasitology International, vol.47, issue.2, pp.95-99, 1998.
DOI : 10.1016/S1383-5769(98)00010-5

D. Mcmanus, D. Gray, W. Zhang, and Y. Yang, Diagnosis, treatment, and management of echinococcosis, BMJ, vol.344, issue.jun11 1, p.3866, 2012.
DOI : 10.1136/bmj.e3866

J. Keiser and J. Utzinger, Food-Borne Trematodiases, Clinical Microbiology Reviews, vol.22, issue.3, pp.466-483, 2009.
DOI : 10.1128/CMR.00012-09

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708390

J. Mccarthy, A Research Agenda for Helminth Diseases of Humans: Diagnostics for Control and Elimination Programmes, PLoS Neglected Tropical Diseases, vol.81, issue.2, p.1601
DOI : 10.1371/journal.pntd.0001601.s006

G. Santana and B. , The Diagnosis of Human Fascioliasis by Enzyme-Linked Immunosorbent Assay (ELISA) Using Recombinant Cathepsin L Protease, PLoS Neglected Tropical Diseases, vol.82, issue.9, p.2414, 2013.
DOI : 10.1371/journal.pntd.0002414.t001

G. Wendt and J. Collins, Schistosomiasis as a disease of stem cells, Current Opinion in Genetics & Development, vol.40, 2016.
DOI : 10.1016/j.gde.2016.06.010

T. Wang, Transmission of Schistosoma japonicum by humans and domestic animals in the Yangtze River valley, Anhui province, China, Acta Tropica, vol.96, issue.2-3, pp.2-3, 2005.
DOI : 10.1016/j.actatropica.2005.07.017

M. Sangfuang, Schistosoma mekongi cathepsin B and its use in the development of an immunodiagnosis, Acta Tropica, vol.155, pp.11-20
DOI : 10.1016/j.actatropica.2015.11.017

H. Moné, Natural Interactions between S. haematobium and S. guineensis in the Republic of Benin, The Scientific World Journal, vol.2012, 2012.

M. Robinson and J. Dalton, Zoonotic helminth infections with particular emphasis on fasciolosis and other trematodiases, Philosophical Transactions of the Royal Society B: Biological Sciences, vol.13, issue.10, pp.2763-2776, 1530.
DOI : 10.1016/j.exppara.2006.05.004

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865092

R. Barsoum, G. Esmat, and T. El-baz, Human Schistosomiasis: Clinical Perspective: Review, Journal of Advanced Research, vol.4, issue.5, pp.433-444, 2013.
DOI : 10.1016/j.jare.2013.01.005

URL : http://doi.org/10.1016/j.jare.2013.01.005

J. Darren and . Gray, Diagnosis and management of schistosomiasis, BMJ, vol.342, p.2651, 2011.

C. Greenaway, Dracunculiasis (guinea worm disease), CMAJ Feb, vol.17, issue.1704, pp.495-500, 2004.

S. Cairncross, R. Muller, and N. Zagaria, Dracunculiasis (Guinea Worm Disease) and the Eradication Initiative, Clinical Microbiology Reviews, vol.15, issue.2, pp.223-269, 2002.
DOI : 10.1128/CMR.15.2.223-246.2002

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC118073

M. Hours and C. Cairncross, Long-term disability due to guinea worm disease, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.88, issue.5, pp.559-60, 1994.
DOI : 10.1016/0035-9203(94)90163-5

URL : http://trstmh.oxfordjournals.org/cgi/content/short/88/5/559

A. Issaka-tinorgah, P. Magnussen, P. Bloch, and A. Yakubu, Lack of effect of ivermectin on prepatent guinea-worm: a single-blind, placebo-controlled trial, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.88, issue.3, pp.346-354, 1994.
DOI : 10.1016/0035-9203(94)90111-2

M. Gentilini, D. Richard-lenoble, and . Dracunculose, Médecine tropicale, 6e édition

R. Muller, Guinea worm disease; epidemiology, control and treatment, Bull World Health Organ, vol.57, issue.5, pp.683-689, 1979.

K. Otabil and S. Tenkorang, Filarial hydrocele: a neglected condition of a neglected tropical disease, The Journal of Infection in Developing Countries, vol.9, issue.05, pp.456-62, 2015.
DOI : 10.3855/jidc.5346

M. Cholewi?ski, M. Derda, and E. Hada?, Parasitic diseases in humans transmitted by vectors, Ann Parasitol, vol.61, issue.3, pp.137-57, 2015.

J. Cross and . Nematodes, Medical Microbiology, 1996.

R. Shenoy, Clinical and Pathological Aspects of Filarial Lymphedema and Its Management, The Korean Journal of Parasitology, vol.46, issue.3
DOI : 10.3347/kjp.2008.46.3.119

W. Müssner, J. Bösch, D. Buhl, J. Neuweiler, and K. Bandhauer, Filaria: a tropical disease as the etiology of acute scrotum. [Article in German]. Urologe A, pp.84-90, 1997.

N. Chaubal, G. Pradhan, J. Chaubal, and S. Ramani, Dance of Live Adult Filarial Worms Is a Reliable Sign of Scrotal Filarial Infection, Journal of Ultrasound in Medicine, vol.22, issue.8, pp.765-774, 2003.
DOI : 10.7863/jum.2003.22.8.765

A. Eigege, Rapid assessment for lymphatic filariasis in central Nigeria: a comparison of the immunochromatographic card test and hydrocele rates in an area of high endemicity, Am J Trop Med Hyg, vol.68, issue.6, pp.643-649, 2003.

P. Gayen, A double-blind controlled field trial of doxycycline and albendazole in combination for the treatment of bancroftian filariasis in India, Acta Tropica, vol.125, issue.2, pp.150-156, 2013.
DOI : 10.1016/j.actatropica.2012.10.011

J. Ollapallil and D. Watters, Surgical management of elephantiasis of male genitalia, British Journal of Urology, vol.20, issue.2, 1995.
DOI : 10.1111/j.1464-410X.1995.tb07677.x

A. Crump, C. Morel, and S. Omura, The onchocerciasis chronicle: from the beginning to the end ? Trends in Parasitology, pp.280-288, 2012.

D. Udall, Recent Updates on Onchocerciasis: Diagnosis and Treatment, Clinical Infectious Diseases, vol.44, issue.1, pp.53-60, 2007.
DOI : 10.1086/509325

URL : http://cid.oxfordjournals.org/cgi/content/short/44/1/53

F. Tamarozzi, A. Halliday, K. Gentil, A. Hoerauf, E. Pearlman et al., Onchocerciasis: the Role of Wolbachia Bacterial Endosymbionts in Parasite Biology, Disease Pathogenesis, and Treatment, Clinical Microbiology Reviews, vol.24, issue.3, pp.459-468, 2011.
DOI : 10.1128/CMR.00057-10

G. Braun, N. Mckechnie, and W. Gürr, Molecular and immunological characterization of hr44, a human ocular component immunologically cross-reactive with antigen Ov39 of Onchocerca volvulus, Journal of Experimental Medicine, vol.182, issue.4
DOI : 10.1084/jem.182.4.1121

P. Lamberton and P. Jourdan, Human Ascariasis: Diagnostics Update, Current Tropical Medicine Reports, vol.90, issue.Suppl 3, pp.189-200, 2015.
DOI : 10.1007/s40475-015-0064-9

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630244

N. Das and N. Das, Treatment of Tropical Diseases, World Scientific News, vol.45, issue.1, pp.2016-2017

P. Bourée, Antihelminthiques et trichocéphale, John Libbey Eurotext, vol.24, issue.4, 1988.

B. Speich, Infection, New England Journal of Medicine, vol.370, issue.7, pp.610-620, 2014.
DOI : 10.1056/NEJMoa1301956

K. Bouhoum, K. Habbari, and J. M. , Étude épidémiologique des helminthiases intestinales chez l'enfant de la zone d'épandage des eaux usées de la ville de Marrakech, Conception, naissance et petite enfance au Maghreb. Collection : Les Cahiers de l'Iremam. Lieu d'édition : Aix-en-Provence, 1997.
DOI : 10.4000/books.iremam.2929

URL : http://books.openedition.org/iremam/2929

J. Pays, Chagas Carlos Justiniano Ribeiro (1879?1934), Bull. Soc. Pathol. Exot, vol.102, pp.276-279, 2009.

K. Tyler, C. Olson, and D. Engman, The Life Cycle Of Trypanosoma Cruzi, World class parasites, vol.7, pp.1-11, 2003.
DOI : 10.1007/978-1-4419-9206-2_1

G. Schmunis, Prevention of transfusional Trypanosoma cruzi infection in Latin America, Mem??rias do Instituto Oswaldo Cruz, vol.94, issue.1, pp.93-101, 1999.
DOI : 10.1590/S0074-02761999000700010

S. Blanchy, Compte rendu de l'atelier n°1. Populations à risque de maladie de Chagas en France métropolitaine et maladie de Chagas congénitale, Bull Soc Pathol Exot, vol.102, pp.330-332, 2009.

J. Maguire, Chagas' Disease ??? Can We Stop the Deaths?, New England Journal of Medicine, vol.355, issue.8, pp.760-761, 2006.
DOI : 10.1056/NEJMp068130

G. Schmunis and Z. Yadon, Chagas disease: A Latin American health problem becoming a world health problem, Acta Tropica, vol.115, issue.1-2, pp.1-214, 2010.
DOI : 10.1016/j.actatropica.2009.11.003

F. Boissier, L'atteinte cardiaque de la maladie de Chagas, à propos d'une observation. La lettre du cardiologue, pp.32-34, 2006.

A. Rassi, . Jr, A. Rassi, and J. Marin-neto, Chagas disease. Lancet, Apr, vol.17, issue.3759723, pp.1388-402, 2010.

A. Teixeira, M. Hecht, M. Guimaro, A. Sousa, and N. Nitz, Pathogenis of Chagas disease : parasite persistance and autoimmunity. Clinical Microbiology Reviews, pp.592-630, 2011.

L. Loup, G. Ibrahim, K. Malvy, and D. , Maladie de Chagas et immunodépression: Infection par le VIH et transplantation, Bull. Soc. Pathol. Exot, vol.102, pp.310-318, 2009.

A. Gay, Compte rendu de l'atelier n°3 Dépistage et diagnostic biologique de la maladie de Chagas, Bull Soc Pathol Exot, vol.102, pp.338-441, 2009.

A. Wolf, Le nifurtimox, molécule en plein devenir dans le traitement de la maladie de Chagas, Med Trop, vol.72, pp.131-133, 2011.

C. Coilliot, Le benznidazole un des rares traitements de la maladie de Chagas, Med trop, vol.71, pp.341-342, 2011.

C. Schofield, The future of Chagas disease control, Trends in Parasitology, vol.22, issue.12, pp.583-588, 2006.
DOI : 10.1016/j.pt.2006.09.011

D. Malvy, F. Chappuis, and F. , Sleeping sickness, Clinical Microbiology and Infection, vol.17, issue.7, pp.986-95, 2011.
DOI : 10.1111/j.1469-0691.2011.03536.x

F. Njiokou, in sleeping sickness foci in Cameroon, Parasite, vol.17, issue.1, pp.61-66, 2010.
DOI : 10.1051/parasite/2010171061

H. Talabania and T. Ancellea, Le diagnostic de la trypanosomiase humaine africaine. Revue francophone des laboratoires, p.430, 2011.

G. Dawit, Z. Girma, and K. Simenew, Epidemiology and Public Health Significance of Leishmaniasis, A Review on Biology J Bacteriol Parasitol, issue.2, 2013.

F. Chappuis, S. Sundar, A. Hailu, H. Ghalib, S. Rijal et al., Visceral leishmaniasis : what are the needs for diagnosis, treatment and control? Nat Rev Microbiol, 2007.

R. Reithinger and J. Dujardin, Molecular Diagnosis of Leishmaniasis: Current Status and Future Applications, Journal of Clinical Microbiology, vol.45, issue.1, pp.21-25, 2007.
DOI : 10.1128/JCM.02029-06

J. Alvar, I. Velez, C. Bern, M. Herrero, P. Desjeux et al., Leishmaniasis Worldwide and Global Estimates of Its Incidence, PLoS ONE, vol.83, issue.30, p.35671, 2012.
DOI : 10.1371/journal.pone.0035671.s101

J. Ramirez, S. Adugelo, and C. Muskus, Diagnosis of cutaneous leishmaniasis in Colombia: the sampling site within lesions influences the sensititivity of parasitological diagnosis, J Clin Microbiol, vol.38, issue.10, pp.3768-73, 2000.

H. De-vries, S. Reedijk, and H. Schallig, Cutaneous Leishmaniasis: Recent Developments in Diagnosis and Management, American Journal of Clinical Dermatology, vol.15, issue.5, pp.99-109
DOI : 10.1007/s40257-015-0114-z

J. Oliveira, Polymerase chain reaction (PCR) is highly sensitive for diagnosis of mucosal leishmaniasis, Acta Tropica, vol.94, issue.1, pp.55-59, 2005.
DOI : 10.1016/j.actatropica.2004.12.003

I. Nachamkin, B. Allos, T. Ho, and T. , Campylobacter Species and Guillain-Barré Syndrome, Clin Microbiol Rev, vol.11, issue.3, pp.555-567, 1998.

M. Lunn and R. Hughes, The Relationship between Cytomegalovirus Infection and Guillain-Barre Syndrome, Clinical Infectious Diseases, vol.52, issue.7, pp.845-847, 2011.
DOI : 10.1093/cid/cir082

C. Malet, Histoire de la lèpre et de son influence sur la littérature et les arts, pp.155-157, 1967.

J. Languillon, Précis de léprologie, 2 e édition, 1986.

B. Desmarest, La lèpre et son traitement actuel, 1986.

J. Schémann, Le trachome: Une maladie de la pauvreté, IRD Editions. Marseille, 2008.
DOI : 10.4000/books.irdeditions.2420

G. Lachenal, Le médicament qui devait sauver l'Afrique, un scandale pharmaceutique aux colonies, p.90

G. Ollivier and D. Legros, Trypanosomiase humaine africaine: historique de la thérapeutique et de ses echecs. Tropical Medicine and International Health, pp.855-863, 2001.
DOI : 10.1046/j.1365-3156.2001.00753.x

F. Darriet, Des moustiques et des hommes, chronique d'une pullulation annoncée, IRD Editions
DOI : 10.4000/books.irdeditions.9275

A. Fenwick, The global burden of neglected tropical diseases. Public Health, 2012.

P. Hotez, Incorporating a Rapid-Impact Package for Neglected Tropical Diseases with Programs for HIV/AIDS, Tuberculosis, and Malaria PLoS Med, p.102, 2006.

S. Brooker, The co-distribution of Plasmodium falciparum and hookworm among African schoolchildren, Malaria Journal, vol.5, issue.1, pp.99-107, 2006.
DOI : 10.1186/1475-2875-5-99

M. Balasegaram, Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of Congo, Bulletin of the World Health Organization, vol.84, issue.10, pp.783-791, 2006.
DOI : 10.2471/BLT.06.031955

O. Yun, NECT Is Next: Implementing the New Drug Combination Therapy for Trypanosoma brucei gambiense Sleeping Sickness, PLoS Neglected Tropical Diseases, vol.16, issue.5, p.720, 2010.
DOI : 10.1371/journal.pntd.0000720.g001

A. Musa, Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial, PLoS Neglected Tropical Diseases, vol.21, issue.2, p.1674, 2012.
DOI : 10.1371/journal.pntd.0001674.s002

T. Jha, Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India ?? Commentary: Some good news for treatment of visceral leishmaniasis in Bihar, BMJ, vol.316, issue.7139, pp.1200-1205, 1998.
DOI : 10.1136/bmj.316.7139.1200

C. Thakur, Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.94, issue.4, pp.432-433, 2000.
DOI : 10.1016/S0035-9203(00)90131-7

C. Thakur, A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.94, issue.4, pp.429-431, 2000.
DOI : 10.1016/S0035-9203(00)90130-5

S. Sundar, Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian Epidemic, Clinical Infectious Diseases, vol.31, issue.4, pp.1104-1151, 2000.
DOI : 10.1086/318121

S. Sundar, Drug resistance in Indian visceral leishmaniasis, Tropical Medicine and International Health, vol.793, issue.11, pp.849-54, 2001.
DOI : 10.1086/318122

URL : http://onlinelibrary.wiley.com/doi/10.1046/j.1365-3156.2001.00778.x/pdf

S. Sundar and H. Murray, Availability of miltefosine for the treatment of kala-azar in India. Bull World Health Organ, pp.394-395, 2005.

T. Dorlo, M. Balasegaram, J. Beijnen, and P. De-vries, Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis, Journal of Antimicrobial Chemotherapy, vol.67, issue.11, pp.2576-2597, 2012.
DOI : 10.1093/jac/dks275

H. Sindermann and J. Engel, Development of miltefosine as an oral treatment for leishmaniasis, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.100
DOI : 10.1016/j.trstmh.2006.02.010

S. Sundar, Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial, The Lancet, vol.377, issue.9764, pp.477-86, 2011.
DOI : 10.1016/S0140-6736(10)62050-8

S. Sundar, J. Chakravarty, D. Agarwal, M. Rai, and H. Murray, Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India, New England Journal of Medicine, vol.362, issue.6, pp.504-512, 2010.
DOI : 10.1056/NEJMoa0903627

Y. Carlier and F. Torrico, Congenital infection with Trypanosoma cruzi: from mechanisms of transmission to strategies for diagnosis and control. Rev Soc Bras Med Trop, 2003.

A. Tarral, Determination of an Optimal Dosing Regimen for Fexinidazole, a Novel Oral Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Studies, Clinical Pharmacokinetics, vol.48, issue.5, pp.565-580, 2014.
DOI : 10.1007/s40262-014-0136-3

G. Eperon, Treatment options for second-stage gambiense human African trypanosomiasis, Expert Review of Anti-infective Therapy, vol.12, issue.11, pp.1407-1417, 2014.
DOI : 10.1586/14787210.2014.959496

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743611

M. Asada, Development and Distribution of Drugs for NTDs: Efforts of One Pharmaceutical Company, YAKUGAKU ZASSHI, vol.136, issue.2, pp.223-253, 2016.
DOI : 10.1248/yakushi.15-00233-3

M. Bahia, Antitrypanosomal Activity of Fexinidazole Metabolites, Potential New Drug Candidates for Chagas Disease, Antimicrobial Agents and Chemotherapy, vol.58, issue.8, pp.4362-70
DOI : 10.1128/AAC.02754-13

M. Pinazo, Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives, Mem??rias do Instituto Oswaldo Cruz, vol.110, issue.3, pp.422-432
DOI : 10.1590/0074-02760140435

H. 145-van-den-berg, Global Trends in the Use of Insecticides to Control Vector-Borne Diseases, Environmental Health Perspectives, vol.120, issue.4, pp.577-582, 2012.
DOI : 10.1289/ehp.1104340

G. Matthews, Status of Legislation and Regulatory Control of Public Health Pesticides in Countries Endemic with or at Risk of Major Vector-Borne Diseases, Environmental Health Perspectives, vol.119, issue.11, pp.1517-1522, 2011.
DOI : 10.1289/ehp.1103637

K. Ziegelbauer, Effect of Sanitation on Soil-Transmitted Helminth Infection: Systematic Review and Meta-Analysis, PLoS Medicine, vol.88, issue.1, p.1001162
DOI : 10.1371/journal.pmed.1001162.s003

J. Bethony, Vaccines to combat the neglected tropical diseases, Immunological Reviews, vol.2, issue.Suppl, pp.237-270, 2011.
DOI : 10.1111/j.1600-065X.2010.00976.x

D. Normile, First New Dengue Virus Type in 50 Years Disponible sur : http://www.sciencemag.org/news/2013/10/first-new-dengue-virus-type-50-years, Science, vol.21, 2013.

O. Rabies, Fact Sheet Disponible sur : http://www.who.int/mediacentre, 2016.

W. Trachoma, Fact sheet Disponible sur : http://www.who.int/mediacentre, 2016.

S. Mariotti and A. Prüss, La stratégie CHANCE : prévenir le trachome. OMS Disponible sur : http://www.who.int/blindness/CHANCE_fr.pdf?, p.1, 2001.

F. Portaels, . World-health, and . Organization, Laboratory diagnosis of Buruli ulcer: A manual for health-care providers, Disponible sur, 2014.

P. Aubry, Les tréponématoses endémiques : pian, bejel. Actualités 2013 Mise à jour le 15, Disponible sur, 2013.

W. Yaws, Fact sheet Disponible sur : http://www.who.int/mediacentre, 2016.

P. Solano, Concurrence internationale autour des maladies tropicales négligées Le Figaro santé Disponible sur : http://sante.lefigaro.fr/actualite, p.24616, 2016.

W. Echinococcosis, Fact sheet Disponible sur : http://www.who.int/mediacentre, 2016.

J. Eckert, M. Gemmell, F. Meslin, Z. Paw?owski, . Who et al., OIE Manual on Echinococcosis in Humans and Animals: a Public Health Problem of Global Concern Disponible sur : http://apps.who.int/iris/bitstream, 2001.

W. Schistosomiasis, Fact sheet Disponible sur : http://www.who.int/mediacentre, 2016.

O. Eradication-de-la-dracunculose, Disponible sur : http://apps.who.int/iris/bitstream, 2008.

W. Onchocerciasis, Fact sheet Disponible sur : http://www.who.int/mediacentre, 2016.

C. The and . Center, Onchocerciasis Elimination Program for the Americas (OEPA) Disponible sur, 2016.

. Novartis, Novartis continues commitment to go the last mile in effort to eliminate leprosy Disponible sur : https://www.novartis.com/news/media-releases/novartis-continuescommitment-go-last-mile-effort-eliminate-leprosy, 2015.

D. L. Salomon and . Pasteur, la rage de guérir. 28 janvier 2013 Disponible sur : https://destinationsante.com/louis-pasteur-la-rage-de-guerir.html, 2016.

A. King, Historical Perspective of Rabies in Europe and the Mediterranean Basin : A testament to rabies. OIE (World organisation for animal health), Disponible sur, 2004.

J. André and . Lomidine, le médicament qui devait sauver l'Afrique : interview de l'anthropologue

G. Lachenal, Disponible sur: http://afrique.lepoint.fr/actualites/lomidine-le- medicament-qui-devait-sauver-l, 2014.

. Invs and . Chikungunya, Données de la surveillance renforcée en France métropolitaine en 2016 Mis à jour le 26 septembre 2016 Disponible sur : http://invs.santepubliquefrance.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies-a- transmission-vectorielle/Chikungunya/Donnees-epidemiologiques/France- metropolitaine/Chikungunya-dengue-et-zika-Donnees-de-la-surveillance-renforcee-en-France- metropolitaine, 2016.

P. Black and M. Nunn, Conséquences du changement climatique et des modifications environnementales sur les maladies animales émergentes ou ré-émergentes et sur la production animale, 2016.

M. Ndour, Partenariats public-privé mondiaux pour la santé : l'émergence d'une gouvernance transnationale des problèmes de santé des pays en développement ? Institut du développement durable et des relations internationales, juillet 2006, Disponible sur, 2016.

O. and P. Contre-la-lèpre, Développement et mise en oeuvre depuis 25 ans Disponible sur : http://apps.who.int/iris/bitstream, 2006.

P. La, Presque plus de recherche pour les maladies " négligées " . La Revue Prescrire, Disponible sur, pp.457-458, 2002.

S. Gaitzsch, . Interview-de-bernard, and . Pécoul, Disponible sur : http://www.invivomagazine.com/fr/mens_sana/interview/article/180/bernard-pecoul-les- pharmas-ne-s-interessent-pas-aux-populations-pauvres, Magazine In Vivo. 3 juillet 2015, 2016.

J. Badina, Maladies négligées : les industriels s'impliquent. Pharmaceutiques. Janvier 2014 Disponible sur : http://www.dndi.org/wp-content/uploads, 2014.

M. Sans and F. , Pretoria : chronique d'un mauvais procès. 29 Avril Disponible sur : http://www.msf.fr/actualite/articles/pretoria-chronique-mauvais-proces, 2002.

I. Centre, S. Trade, and . Development, ADPIC : L'UE adopte l'accord OMC sur les médicaments génériques. 30 Novembre Disponible sur, 2007.

C. Hecketsweiler, Les maladies négligées : pourquoi les labos s'y intéressent, 2013.

. Sciences-au-sud, . Interview-de-bernard-pécoul, and . Dndi, Sciences au Sud n°75 Juillet-août 2014 Disponible sur : https://www.ird.fr/la-mediatheque/journal-sciences-au- sud/les-numeros-de-sciences-au-sud/n-75-juillet-aout-2014/sciences-au-sud-n-75-interview- bernard-pecoul-directeur-executif-du-dndi-drugs-for-neglected-diseases-initiative, 2016.

. Dndi, NECT ? combinaison thérapeutique contre la maladie du sommeil ? inclus dans la liste des médicaments essentiels de l'OMS. 15 mai Disponible sur : http://www.dndi.org/2009/media-centre/langues-press-releases/nect-combinaison-therapeutique- contre-la-maladie-du-sommeil-inclus-dans-la-liste-des-medicaments-essentiels-de-loms, 2009.

. Dndi and . Nect, Nifurtimox-Eflornithine Combination Therapy, now available Disponible sur : http://www.dndi, 2009.

. Dndi, . Ssg&pm, and . Mai, Disponible sur : http://www.dndi, 2009.

. Dndi and . Lafepe, Benznidazole 12, 5 mg, now registrable in Brazil. Décembre Disponible sur : http://www.dndi, 2009.

. Dndi, SCYX-7158 Oxaborole Last update Disponible sur : http://www.dndi.org/diseases-projects/portfolio/scyx-7158, 2016.

. Dndi, V. New, ?. Treatments, and . America, Last update Disponible sur : http://www.dndi.org/diseases-projects/portfolio/new-vl-treatments-latam, 2015.

. Dndi, New Treatments for PKDL Last update Disponible sur : http://www.dndi.org/diseases-projects, 2016.

. Dndi and +. New-benz-regimens, Last update Disponible sur : http://www.dndi.org/diseases-projects/portfolio/new-benz-regimens, 2016.

. Dndi and . Fexinidazole, Last update Disponible sur : http://www.dndi.org/diseases-projects, 2016.

. Dndi and . Emodepside, Last update Disponible sur : http://www.dndi.org/diseasesprojects, 2016.

A. Dndi and . Tylamac, Last update Disponible sur : http://www.dndi.org/diseases-projects, 2016.

. Dndi and . Biomarkers, Last update Disponible sur : http://www.dndi.org/diseasesprojects, 2016.